|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 10, 2015 ) This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, Acquisition and Joint Venture activity; their Research & Development spending; as well as Strength, Weakness, Opportunity and Threats that each individual company faces. This report also offers a snapshot of the key financials in the India pharmaceutical sector; import / export values, and where the India based pharmaceutical companies are generating their revenue globally. The report concludes with interviews with directors of Ipca Laboratories, Cadila Healthcare and Cipla.
The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;
Key Drivers
US Generics Market
JV, Acquisitions & Mergers
Patent Cliff
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=487486
Increased Domestic Health Spending
Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
Economies in Drug Production/Manufacture
Governmental Support
Key Restraints
Industry Inefficiencies
Regulatory Non-Compliance
Price Ceilings
Intellectual Property Rights / Compulsory Licence
Inadequate Health Insurance, India
The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Data’s list generating over 50% of their annual revenues from the US generics market. However with access to the US market comes increased scrutiny from the US FDA; nearly all the companies in the top ten have faced warnings from the FDA; ranging from minor procedural infractions to complete manufacturing shutdown.
The report contains over 130 tables & figures across 152 pages and concludes with 3 exclusive interviews with managing directors of 3 leading Indian pharmaceutical companies;
Cipla
Cadila Healthcare
IPCA Laboratories
Browse Detail Report With TOC @ http://www.researchmoz.us/the-indian-pharmaceutical-market-leading-domestic-companies-2015-report.html
Table of Content
1 Executive Summary
1.1 Executive Summary
1.2 Research and Analysis Methods
1.3 Drivers & Restraints
1.3.1 Drivers
1.3.1.1 US Generics Market
1.3.1.2 JV, Acquisitions & Mergers
1.3.1.3 Patent Cliff
1.3.1.4 Increased Domestic Health Spending
1.3.1.5 Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
1.3.1.6 Economies in Drug Production/Manufacture
1.3.1.7 Governmental Support
1.3.2 Restraints
1.3.2.1 Industry Inefficiencies and Regulatory Non-Compliance
1.3.2.2 Price Ceilings
1.3.2.3 Intellectual Property Rights / Compulsory Licence
1.3.2.4 Inadequate Health Insurance, India
2 Indian Pharmaceutical Market Overview
2.1 Evolution of the India Pharmaceutical Sector
2.1.1 Key Reforms/Regulations
2.1.2 Customers/End-Users
2.1.3 Pricing/Reimbursement
2.1.4 Competitive Landscape
3 India Pharmaceutical Market Revenue
3.1 Pharmaceutical Market Revenue - Domestic
3.2 Pharmaceutical Market Revenue – Export
3.3 Domestic Pharmaceutical Drugs Market Share
4 – The 10 Leading Indian Pharmaceutical Companies 2015
4.0.1 The Top Ten India Pharmaceutical Companies FY2015, by Revenue
4.0.2 The Top Ten Domestic & Foreign Revenue Generators FY2015
4.0.3 The Top Ten R&D Spending FY2015
4.1 Sun Pharmaceutical Industries Ltd
4.1.1 Sun Pharma Company Profile
4.1.2 Sun Pharma Financial Analysis
4.1.3 Sun Pharma SWOT Analysis
4.1.3.1 Strengths
4.1.3.1.1 Robust R&D Spending
4.1.3.1.2 Strong Drugs Pipeline
4.1.3.1.3 Strong Position in Key Markets
4.1.3.2 Weaknesses
4.1.3.2.1 Export Dependency
4.1.3.3 Opportunities
4.1.3.3.1 Capitalisation on the Ranbaxy Acquisition
4.1.3.3.2 Further Acquisition
4.1.3.4 Threats
4.1.3.4.1 FDA warnings
4.1.3.4.2 Ranbaxy Merger Issues
4.2 Dr Reddy's Laboratories Ltd.
4.2.1 Dr Reddy’s Company Profile
4.2.2 Dr Reddy’s Financial Analysis
4.2.3 Dr Reddy SWOT Analysis
4.2.3.1 Strengths
4.2.3.1.1 Global Presence through Strategic Acquisitions and Partnerships
4.2.3.1.2 Generic Sales in Key Geographies
4.2.3.1.3 Strong Operational Infrastructure and Robust Base for Research
4.2.3.2 Weaknesses
4.2.3.2.1 Increased R&D spending to put Pressures on Margins
4.2.3.3 Opportunities
4.2.3.3.1 Growth in US Generic Market
4.2.3.3.2 Biosimilars Market Opportunity
4.2.3.4 Threats
4.2.3.4.1 Economic / Political Uncertainties in Some Markets
4.2.3.4.2 Manufacturing Issues Leading to FDA Scrutiny / Drug Recalls
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=487486
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
For More Reports Please Visit @ http://www.prnewswire.com/news/researchmoz
For More Reports Please Visit @ http://www.sbwire.com/search/?q=researchmoz
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
